The more data that is released, the more deadly and dangerous the vaccine is proven to be.
One week after receiving a first dose of Pfizer/BioNTech’s COVID-19 vaccine, a previously healthy young woman in her 20s presented to the emergency department at Sharp Memorial Hospital in San Diego, complaining she was urinating frequently. Her family was more concerned that she was increasingly anxious, not sleeping well, not mentally acute, and was fixated on the belief that she was suffering from kidney disease and irritable bowels. She had no history of mental illness but was convinced that she had contracted COVID-19 and that her body was “shutting down.” Her family also noticed that she had trouble communicating and seemed to have difficulty with motor control at times. Blood and urine tests taken on this visit were normal, although her heartbeat was fast and her blood pressure was elevated, according to the case report published earlier this month in Frontiers in Neurology. She was sent home.
The following day, the young woman returned to the hospital, this time complaining that she was hearing accusatory voices. A COVID PCR test was negative, but further testing revealed two elevated liver enzymes. Her blood pressure was still up, and her heart was racing, so she was hospitalized. The following morning, she took off all her clothes in her hospital room and defecated on the floor.
Doctors began treating the young woman with psychiatric drugs, but she only became “increasingly psychotic,” according to the case report. A prescription of lithium was tried, and then abandoned, when she became catatonic. She was put on another drug, Risperidone, and then suffered a grand mal seizure.
Her memory was intact, and the young woman responded to doctors’ questions, but only in short sentences, in a monotone flat voice. She was lethargic with lingering symptoms of catatonia. She could walk, but slowly, and had to be prompted to move.
A lumbar puncture (spinal tap) and analysis of the young woman’s cerebrospinal fluid (CSF) revealed elevated white blood cells which was evidence of inflammation within her nervous system. Spinal fluid and blood tests for a list of viruses from herpes simplex and Epstein-Barr virus to HIV were negative.
“The constellation of symptoms (spontaneous defecation, catatonia, sudden encephalopathy without metabolic or infectious findings) coupled with the preliminary CSF results and the history of deterioration after SARS-CoV-2 vaccination led to a strong clinical suspicion of an autoimmune-mediated encephalitis driven by the vaccine,” states the paper written by doctors at the Salk Institute of Biological Studies, Sharp Memorial Hospital, in San Diego, and the Center for Immunity, Infection and Inflammation at the University of California-San Diego School of Medicine in La Jolla, CA.
Eventually, CSF tests confirmed the diagnosis of Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis – an autoimmune condition characterized by neuropsychiatric syndromes and the presence of antibodies against glutamate (GluN1) receptors detectable in the spinal fluid.
Anti-NMDAR encephalitis has been associated with viral illnesses such as Japanese encephalitis, Epstein-Barr virus, and COVID infection. It has also been associated with vaccinations against H1N1, yellow fever, TdaP-IPV booster, and Japanese Encephalitis. New onset psychosis has been associated with other vaccines as well, including for rabies and smallpox.
The 2018 documentary Malcolm is a Little Unwell depicts the ordeal of British veteran foreign affairs correspondent Malcolm Brabant’s descent into psychosis after he got a yellow fever vaccine to travel.
After ruling out all other potential causes, the young woman was treated with immunoglobulins and rituximab – a drug used for autoimmune conditions – and steroid therapy. She gradually improved and, 61 days after her first dose of the COVID shot and 45 days in the hospital, she was discharged with “minor neurological deficits.” She remained on anticonvulsant drugs for seizures three months later but was able to return to work.
Other case reports
Though the researchers describe this as the “first instance of anti-NMDAR encephalitis after receiving the Pfizer-BioNTech COVID-19 vaccine,” other case reports of sudden onset psychosis following COVID vaccination are already in the medical literature.
One case report published in Psychiatry Research in October describes a previously healthy 31-year-old, single Hispanic office manager who police brought to the emergency room because of his “erratic and bizarre behavior.” He was anxious, guarded, and claimed to be “clairvoyant,” and able to talk with dead people, hearing “people drumming outside his house,” and the constant voice of a co-worker whom he believed to be a paramour, but it turned out, with whom he had no romantic relationship.
U.K. reports on child deaths from the Office for National Statistics (ONS) show that, in the weeks since the COVID shot has been administered to children between ages 12 and 15, recorded deaths have risen by 44 percent above the 2015-2019 average for the same time period.
According to the ONS’ “five-year average weekly deaths by sex and age group” figures between 2015 and 2019 among children ages 10-14, there were 41 deaths recorded from week 38 (late September) to week 45 (early November). Within the same time period, the weekly figures recorded for the year 2021 show that 59 children died, representing a 43.9 percent rise in deaths over the five-year average.
A report from The Exposé notes that deaths among 10-14-year-olds have been consistently above that of the national five-year average since the shots started being administered to children, save for one week, week 42. Week 38 saw more than double the deaths among the young age group, going from a five-year average of three deaths to eight deaths in 2021.
The single largest weekly death count was observed in week 40, about two weeks after the jab had been rolled out, at which point 11 children died in 2021 compared with the five-year average of four, representing a 175 percent rise in deaths.
Breaking down the data into male and female categories, The Exposé showed that although more boys’ deaths were recorded, 2021 has marked a greater percentage of increase in deaths for girls.
Overall, 24 boys died between weeks 38 and 45 on the five-year average scale, whereas 34 died in 2021, marking a 41.7 percent increase in deaths. The greatest number of boys’ deaths were recorded in Week 40, during which time seven boys died, up 250 percent from the five-year average.
Among girls age 10–14, ONS records show an average increase of 47 percent in weeks 38 to 45 of 2021 over the five-year average, going from 17 deaths to 25. The greatest weekly record was in week 40, in which four girls ages 10-14 died, up 100 percent from the five-year average.
While the quantities might appear low, the sudden change in recorded deaths is stark. For the 16 weeks before the COVID jab rollout, for example, an increase in deaths of only around 3.9 percent is observed, a factor of 10 less than the weeks thereafter. The highest increase in deaths recorded during the prior 16 weeks was in week 28, in which a 200 percent increase from the five-year average occurred, going from two to six deaths.
Unlike the time after the shots started being administered to 12-year-olds, the earlier period saw some large drops in deaths from the five-year average to now, with the largest decrease in deaths observed in week 23, during which time deaths dropped by 55.6 percent, down to four deaths from nine.
Though there is a pattern of increased deaths since the shots began being used in children, the causes of the deaths were not published.
The push to vaccinate young children comes despite the fact that children face extremely low risk from COVID-19. This combined with the thousands of reports of serious adverse events and deaths after the jabs has led numerous experts to criticize the push to inject children with the experimental shots.
This summer, researchers with Johns Hopkins School of Medicine found a “mortality rate of zero among children without a pre-existing medical condition such as leukemia” when they “analyze[d] approximately 48,000 children under 18 diagnosed with COVID in health-insurance data from April to August 2020.”
In response to the finding, lead researcher Dr. Marty Makary accused the CDC of basing its advocacy of school COVID vaccination on “flimsy data.”
On September 13, 2021, England Chief Medical Officer Chris Whitty advised that the government roll out its COVID-19 vaccination program to children ages 12 and over, with the National Health Service (NHS) deploying a children’s vaccination scheme nationwide by the following Monday, September 20.
Britain Health Secretary Sajid Javid suggested at the time that parents’ wishes could be overruled regarding jabbing their children against COVID, saying “as long as we believe the child is competent enough to make that decision, then the child will prevail.”
The government quickly acted on Whitty’s advice despite weeks earlier receiving contrary advice from the Joint Committee on Vaccination and Immunisation (JCVI), which declared against both the necessity and safety of implementing the jabs for children.
The JCVI, an independent adviser to the U.K. government on immunization programs, determined in a September 3 statement that the “available evidence indicates that the individual health benefits from COVID-19 vaccination are small in those aged 12 to 15 years.” They added that the any benefit granted by the abortion-tainted shots are only “marginally greater than the potential known harms,” while acknowledging that “there is considerable uncertainty regarding the magnitude of the potential harms.”
Given the uncertainty of risks involved with the COVID shots, the JCVI considered the benefits “too small to support advice on a universal programme of vaccination of otherwise healthy 12- to 15-year-old children at this time.”